VirTrial Announces Service for Virtual Site Monitoring Visits to Allow CRA’s Continued Access to Research Sites During COVID-19 Pandemic
Summary
SCOTTSDALE, Ariz.--(BUSINESS WIRE)--VirTrial today announced a new service designed to enable virtual site monitoring visits in the clinical trials industry. The solution enables pharmaceutical sponsors and CROs to evaluate, qualify and routinely monitor research sites for studies without physical travel. “Pharmaceutical sponsors have shown intense interest in this solution due to its ability to cut costs and reduce the time required to evaluate and monitor research sites,” said Deric Frost, VP of Virtual Pre-Site. These are the types of approaches that we are interested in, to continuously enable a better experience for our clients, and we are proud to be a partner with VirTrial in that mission.” For more information on VirTrial’s Virtual Pre-Site service, visit www.virtualpresite.com. VirTrial is a bioscience technology company providing a stable, long-standing telemedicine platform to transform the clinical trial industry.